MaxCyte, Inc. (MXCT)
1.175
+0.04
(+3.07%)
USD |
NASDAQ |
Jun 08, 14:50
MaxCyte EPS Diluted (Quarterly) : -0.0444 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Repligen Corp. | 0.147 |
| Bio-Techne Corp. | 0.3242 |
| BioLife Solutions, Inc. | 0.0241 |
| MindWalk Holdings Corp. | -0.0609 |
| Maravai Lifesciences Holdings, Inc. | -0.0255 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.75M |
| Revenue (Quarterly) | 9.651M |
| Total Expenses (Quarterly) | 14.40M |
| Enterprise Value | 32.75M |
| Gross Profit Margin (Quarterly) | 73.22% |
| Profit Margin (Quarterly) | -49.22% |
| Earnings Yield | -31.23% |
| Normalized Earnings Yield | -27.11 |